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CAROLINE A. CHANDLER**
The advent of each new antibiotic is not an unmixed blessing. The
advantage of acquiring another agent whose range of antibacterial activity
parallels that of already existing antibiotics is somewhat offset by the
necessity of re-evaluating the known in the light of the new unknown. And
involved is not just the effectiveness of one agent versus another, but the
relative cost, potential toxicity, and inherent capacity to induce resistance
of each.
The following is a brief summary of the present status of antibiotic
therapy. In addition to a table listing the drugs of choice for systemic use
against the micro-organisms most commonly involved in clinical infections,
it includes a brief discussion of the principles underlying antibiotic treatment
based on experimental findings. It is neither a review of the literature nor a
handy compendium of drug dosages but rather represents current experi-
ence and thinking in a field in which the author has been working for a
number of years.
Systemic Use
The antibiotics of choice for the treatment of infections are presented in
the table. When two antibiotics are of equal effectiveness, they are so listed.
In general, it will be noted that penicillin is still the drug of choice in
most infections caused by gram positive organisms, both coccal and bacil-
lary, whereas infections caused by gram negative bacteria are best treated
by streptomycin, aureomycin, or terramycin. The group of Neisseria and
the spirochete of syphilis represent notable exceptions to this generalization,
penicillin being still the most effective antibiotic against these gram negative
organisms.
Chloromycetin (chloramphenicol), like aureomycin and terramycin, is a
broad spectrum antibiotic highly effective in a variety of infections but
because of its alleged tendency to produce blood dyscrasias it has dropped
perhaps unjustifiably into third place (effective but perhaps toxic) in most
instances. Where indicated in severe infection, however, it should be used,
provided the risk to life from the infection outweighs the risk of possible
toxicity.
Polymyxin B is one of the most active antibiotics in vitro against gram
negative bacteria but because of its potential nephrotoxicity, its systemic use
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has been severely limited, possibly unduly so. Recent reports would indicate
that polymyxin was not only the drug of choice in a series of cases of enteric
and urinary tract infections, notably those due to Pseudomonas aeruginosa,
but that in the children treated, it showed very little evidence of renal
toxicity. This is confirmed by the author's experience in observing a small
series of premature infants with pseudomonas infections. Polymyxin was
not only efficacious in treatment, but in no instance did it produce any renal
toxic effects.
Neomycin and bacitracin are poorly absorbed agents that have not been
recommended for systemic use because of their toxicity. Yet they too, like
polymyxin, are beginning to find wider favor for oral use against certain
enteric infections because, taken orally, neither one produces significant side
reactions. Neomycin has been found to be an excellent intestinal antiseptic
since it is quite active against both gram positive and gram negative bac-
teria. Bacitracin exerts its effect primarily against gram positive enterococci
and clostridia.
Erythromycin, one of the newer antibiotics, shows a wide range of
activity against many gram positive pathogens and a few gram negative
ones. It seems relatively non-toxic and since it is active against many
staphylococci and streptococci that are resistant to other antibiotics, it
should prove to be a valuable addition to the broad spectrum antibiotics.
Streptomycin still leads the field as a tuberculostatic drug, and it combines
well with other antibiotics for other infections. In tuberculous infections,
the combined use of streptomycin and para-aminosalicylic acid or nicotinic
acid derivatives or both is not only desirable therapeutically but tends also
to reduce the hazard of eighth nerve damage (by reducing the dosage of
streptomycin) and the risk of development of streptomycin resistance.
In severe infections, combinations of antibiotics are sometimes indicated.
In subacute bacterial endocarditis, for example, an adequate combination of
penicillin and streptomycin (gram positive infecting organism) or strepto-
mycin and aureomycin (gram negative infecting organism) may turn the
tide when any of these agents alone will not. Unfortunately, combinations
of antibiotics may result in antagonistic as well as synergistic effects. If
penicillin, streptomycin, neomycin, and bacitracin are considered as one
group (A) and aureomycin, chloramphenicol and terramycin as another
(B), then the members of group A tend to act synergistically towards each
other but antagonistically towards members of group B. Group B agents
tend to potentiate each other but to behave antagonistically if combined with
agents in group A. So, although the last word has not been said, it would
seem advisable to avoid combinations of antibiotics when one alone is effec-
tive and to use only combinations that have been proved to be effective
against infections clinically.
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TABLE 1
ANTIBIOTIC THERAPY: CHOICE OF DRUG
Type of infection
Streptococcal infections:
1. Beta hemolytic
2. Alpha hemolytic
3. Non-hemolytic
4. All enterococci
Staphylococcal infections
Pneumococcal infections
Neisserian infections:
1. N. meningitidis
2. N. gonorrheae
Diphtheritic infections
Tuberculous infections
Anthrax infections
Clostridial infections:
1. Gas gangrene
2. Tetanus
Gram-Neg. bacillary infections:
1. E. coli
2. Kl. pneumoniae
3. Proteus
4. A. aerogenes
5. Ps. aeruginosa
Salmonella infections:
1. S. typhosa
2. Others (Para. A + B)
Shigella infections
Pasteurella infections:
1. P. pestis
2. P. tularense
Brucella infections:
1. Br. melitensis]
2. Br. abortus p
3. Br. suis J
Cholera
Hemophilus infections:
1. H. influenzae meningitis
2. H. pertussis
3. H. ducreyi
Treponema infections
1. Pallidum
2. Pertenue
Peni- Strepto- Aureo- Chloro- Terra- Erythro-
cillin mycin mycin mycetin mycin mycin
1 2 2 3 2
1 2 2 4 2
1 5 2 5 2
2 2 1 3 2
1 2 2 3 2
1 2 2 3 2
1S 6
1 2
1A 5
6 lPAS
1 6
2
5
5
2
2
5
5
4
5
2 3 2
2 3 2
2 5 5
5 5 5
2 5 4
1 6 2 4 2 4
1 6 6 5 5 4
4 2 1 3 1 6
5 1 1 3 2 6
2 iS 5 3 2 6
6 2 1 3 2 6
6 1S 2 4 2 6
4 4 2 3 2 6
5 4 4 3 4 6
6 2 2 3 iS 5
6 1 4 4
6 1 1 3
5
6 2 1 3 2 5
5 2 5 4 5 5
4 iS 1S 3 2
6 4 4 4 4
6 1 2 3 2
4
4
1 6 2 3 2
1 6 2 3 2
1 First choice
2 Second choice
3 Effective but potentially toxic
Blank-Not evaluated
4 Effective in vivo but clinical value not
established
5 Effective in vitro
6 Not effective
S-Sulfadiazine also
A-Antitoxin also
PAS-Para-amino salicylic acid alsoYALE JOURNAL OF BIOLOGY AND MEDICINE
Topical Use
Neomycin topically is the antibiotic of choice against nearly all pyogenic
infections of the skin, mucous membranes, and eyes. It has a very wide
range of activity against both gram positive and gram negative organisms
and it rarely induces hypersensitivity.
Bacitracin has an antibiotic range roughly similar to penicillin but, unlike
penicillin, it maintains its activity in mixed infections and it is essentially
non-sensitizing. It is an excellent agent for treating local skin infections
caused by staphylococci and streptococci.
Polymyxin B is probably the drug of choice for topical use against
pseudomonas infections.
Broad spectrum antibiotics, although effective topically, should, by and
large, be reserved for systemic use in order to reduce the risk of inducing
hypersensitivity.
Prophylactic Use
As the range of effectiveness of antibiotics against infections has been
increased by the discovery of new agents, so too has the use of antibiotics
in the prophylaxis of infections.
Topically, penicillin is of value for the routine prophylaxis of gonorrheal
opthalmia.
In closed communities, penicillin, given by mouth, is useful in the preven-
tion of hemolytic streptococcal or meningococcal infections.
Small daily doses of oral penicillin have been found to be very effective
in the prevention of recurrences of rheumatic fever. (The same is true of
sulfadiazine.) In the rheumatic subject, the intramuscular administration of
procaine penicillin before and after the extraction of teeth, the removal of
tonsils, or for that matter any operative procedure around the nose or
throat, aids materially in preventing the development of subacute bacterial
endocarditis.
The risk of infection after certain "clean" operations, for example, cor-
rective orthopedic surgery, is much decreased by the prophylactic use of
antibiotics. In established infections in which surgical interference is indi-
cated, the proper use of antibiotics greatly facilitates the control of the
postoperative spread of micro-organisms.
Use and Misuse
If chosen and administered intelligently, antibiotics can be depended upon
to produce maximal therapeutic effects with minimal adverse side reactions.
In addition to selecting with care the drug of choice for each particular
infection, it is necessary to keep in mind a few basic principles governing
the administration of these agents.
Antibiotics should be given in large enough doses and for a long enough
time to control the infection. Inadequate treatment is worse than no treat-
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ment at all because it permits the emergence of drug resistant variants of the
infecting micro-organism. With certain antibiotics, such as streptomycin,
resistant variants are prone to appear rapidly. Even with those agents less
apt to give rise to resistant forms, the problem is always potentially there
and as time goes on, more and more micro-organisms are appearing which
seem to be resistant on primary isolation to certain antibiotics. Cross resist-
ance, too, has become an ever-increasing problem. Organisms readily
develop mutual cross resistance to aureomycin, terramycin, and chloram-
phenicol, and there is some evidence to show that resistance to streptomycin
is paralleled by resistance to neomycin. In treating an infection that has
become resistant to one antibiotic, the possibility of cross resistance should
be kept in mind in choosing another agent.
Overly prolonged therapy is just as unwise as inadequate therapy because
it greatly increases the incidence of untoward reactions. In general, if
definite clinical improvement is not evident within two to three days, the
value of further therapy with a given antibiotic should be seriously ques-
tioned and sensitivity tests of the infecting organism should be run against
this and other antibiotics before therapy is resumed.
This last statement must be qualified by a knowledge of the natural
history and pathological nature of the infection. Infectious processes of soft
tissues which are of short duration generally clear up quickly. Those in
bone, in thrombi, and in certain other tissues require longer exposure to the
antibiotic agent. It is also important to know whether the antibiotic has a
bactericidal or a bacteriostatic action against the agent causing the infection.
If the action is bactericidal, the therapeutic response is generally quite
prompt; if bacteriostatic, the response may be slower and treatment must
be more prolonged.
One final word. The indiscriminate use of antibiotics cannot be too
strongly condemned. "Wholesale" treatment with a single antibiotic or
"shotgun" therapy with combinations of antibiotics is bad medicine. No
antibiotic, no matter how innocuous, is completely safe from the standpoint
of potentially undesirable side-effects. One has only to think of the aller-
genicity of penicillin or the gastro-intestinal concomitants of the broad
spectrum antibiotics to know that these agents are not brand names for
sugar coated pink pills. And yet one is constantly aware of the fact that
antibiotics are being prescribed right and left without regard to specific
indications or, worse, with no indications at all.
Whatever dubious psychological advantage there may be in treating a
cold with penicillin, it is surely more than offset by the fact that penicillin is
totally ineffective against cold viruses at best and is a sensitizing drug
to boot.
Antibiotics should prove to be of continuing value in the reduction of
time lost from illness and in preventing needless deaths, if they are used
with care and good judgment.
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